Centessa Pharmaceuticals (CNTA) Research & Development (2022 - 2025)
Historic Research & Development for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $41.6 million.
- Centessa Pharmaceuticals' Research & Development rose 2259.39% to $41.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $178.6 million, marking a year-over-year increase of 4999.33%. This contributed to the annual value of $150.2 million for FY2024, which is 2077.01% up from last year.
- Centessa Pharmaceuticals' Research & Development amounted to $41.6 million in Q3 2025, which was up 2259.39% from $42.7 million recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Research & Development registered a high of $60.9 million during Q4 2024, and its lowest value of $22.7 million during Q1 2024.
- In the last 4 years, Centessa Pharmaceuticals' Research & Development had a median value of $33.7 million in 2023 and averaged $36.5 million.
- As far as peak fluctuations go, Centessa Pharmaceuticals' Research & Development plummeted by 3723.7% in 2023, and later skyrocketed by 10485.26% in 2024.
- Over the past 4 years, Centessa Pharmaceuticals' Research & Development (Quarter) stood at $27.8 million in 2022, then rose by 6.76% to $29.7 million in 2023, then surged by 104.85% to $60.9 million in 2024, then tumbled by 31.72% to $41.6 million in 2025.
- Its last three reported values are $41.6 million in Q3 2025, $42.7 million for Q2 2025, and $33.4 million during Q1 2025.